Dr. Rosner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Fl 1
Baltimore, MD 21201Phone+1 410-328-2575
Education & Training
Albert Einstein College of MedicineClass of 2017
Certifications & Licensure
MD State Medical License 2021 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 53 citationsPeripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy.Michael Hwang, Jenna Vanliere Canzoniero, Samuel Rosner, Guangfan Zhang, James R White
Journal for Immunotherapy of Cancer. 2022-06-01 - 7 citationsAntibody-Drug Conjugates for Lung Cancer: Payloads and Progress.Samuel Rosner, Augusto Valdivia, Hui Jing Hoe, Joseph C Murray, Benjamin Levy
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023-05-01 - 125 citationsMultimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancerValsamo Anagnostou, Noushin Niknafs, Kristen A. Marrone, Daniel C. Bruhm, James R. White
Nature Cancer. 2020-01-13
Press Mentions
Tip Sheet: Johns Hopkins Kimmel Cancer Center Researchers to Present at Asco Annual MeetingMay 26th, 2023- Positive Five-Year Outcomes Seen for Nivolumab in Resectable Lung CancerFebruary 15th, 2023
- Neoadjuvant Nivolumab Shows Long-Term Benefit in Patients with Non-Small Cell Lung CancerFebruary 15th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
